Showing results (151-160 of 1,290) with videos related to
Sort By:
Pageof 129
Nature Reviews. Drug Discovery|March 2, 2011
Probing the links between in vitro potency, ADMET and physicochemical parametersM Paul Gleeson, Anne Hersey, Dino Montanari, et al.Nature Reviews. Drug Discovery|August 20, 2011
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeuticsEric Karran, Marc Mercken, Bart De StrooperNature Reviews. Drug Discovery|November 1, 2011
VemurafenibKeith T Flaherty, Uma Yasothan, Peter KirkpatrickNature Reviews. Drug Discovery|September 17, 2011
Development of subtype-selective oestrogen receptor-based therapeuticsStefan Nilsson, Konrad F Koehler, Jan-Åke GustafssonNature Reviews. Drug Discovery|March 31, 2012
Novel molecular targets for atrial fibrillation therapyDobromir Dobrev, Leif Carlsson, Stanley NattelNature Reviews. Drug Discovery|November 29, 2014
Managing diabetes with nanomedicine: challenges and opportunitiesOmid Veiseh, Benjamin C Tang, Kathryn A Whitehead, et al.Nature Reviews. Drug Discovery|November 8, 2014
Is there new hope for therapeutic matrix metalloproteinase inhibition?Roosmarijn E Vandenbroucke, Claude LibertNature Reviews. Drug Discovery|November 1, 2014
The Critical Path Institute: transforming competitors into collaboratorsMartha BrumfieldNature Reviews. Drug Discovery|November 1, 2014
The predictive safety testing consortium and the coalition against major diseasesDiane Stephenson, John-Michael SauerNature Reviews. Drug Discovery|November 1, 2014
The international serious adverse events consortiumArthur L Holden, Jorge L Contreras, Sally John, et al.Pageof 129